For immediate release |
5 December 2013 |
Futura Medical plc
("Futura" or "the Company")
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES |
||||
|
|
|||
1. Identity of the issuer or the underlying issuer |
Futura Medical plc |
|||
2 Reason for the notification (please tick the appropriate box or boxes): |
||||
An acquisition or disposal of voting rights |
No |
|||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
No |
|||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
No |
|||
An event changing the breakdown of voting rights |
No |
|||
Other (please specify): |
Aggregation of holdings |
Yes |
||
3. Full name of person(s) subject to the |
R.A. Lamb |
|||
4. Full name of shareholder(s) |
- |
|||
5. Date of the transaction and date on |
- |
|||
6. Date on which issuer notified: |
02/12/2013 |
|||
7. Threshold(s) that is/are crossed or |
7%, 8%, 9%, 10% |
|||
8. Notified details: |
|
||||||||||||||||||
A: Voting rights attached to shares |
|
||||||||||||||||||
Class/type of
|
Situation previous |
Resulting situation after the triggering transaction |
|
||||||||||||||||
Number |
Number |
Number |
Number of voting |
% of voting rights |
|
||||||||||||||
Direct |
Indirect |
Direct |
Indirect |
Direct |
Indirect |
||||||||||||||
Ordinary Shares
GB0033278473 |
- |
- |
5,927,000 |
2,625,615 |
5,927,000 |
2,625,615 |
7.62% |
3.37% |
|||||||||||
|
|||||||||||||||||||
|
|
||||||||||||||||||
B: Qualifying Financial Instruments |
|
||||||||||||||||||
Resulting situation after the triggering transaction |
|
||||||||||||||||||
Type of financial |
Expiration |
Exercise/ |
Number of voting |
% of voting |
|
||||||||||||||
n/a |
n/a |
n/a |
n/a |
n/a |
|
||||||||||||||
|
|
||||||||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments |
|
||||||||||||||||||
Resulting situation after the triggering transaction |
|
||||||||||||||||||
Type of financial |
Exercise price |
Expiration date |
Exercise/ |
Number of voting rights instrument refers to
|
% of voting rights
|
|
|||||||||||||
|
|
|
|
|
Nominal |
Delta |
|
||||||||||||
|
|
|
|||||||||||||||||
|
|
||||||||||||||||||
Total (A+B+C) |
|
||||||||||||||||||
Number of voting rights |
Percentage of voting rights |
|
|||||||||||||||||
8,552,615 |
10.99% |
|
|||||||||||||||||
9. Chain of controlled undertakings through which the voting rights and/or the |
|||
R. A Lamb (and wife) |
5,677,000 |
7.30% |
|
R. A Lamb Trust |
250,000 |
0.32% |
|
Shares held by others but connected to R. A Lamb |
2,625,615 |
3.38% |
|
|
|||
Proxy Voting: |
|||
10. Name of the proxy holder: |
n/a |
||
11. Number of voting rights proxy holder will cease to hold: |
n/a |
||
12. Date on which proxy holder will cease to hold voting rights: |
n/a |
||
|
|||
|
Aggregation of holdings held in own name, wife's name, trust and connected parties |
||
14. Contact name: |
Derek Martin |
||
15. Contact telephone number: |
01483 685670 |
||